Louisa Degenhardt1, Grant Sara2, Rebecca McKetin3, Amanda Roxburgh1, Timothy Dobbins1, Michael Farrell1, Lucinda Burns1, Wayne D Hall4,5. 1. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia. 2. Sydney Medical School, Northern Clinical School, University of Sydney, Sydney, Australia. 3. National Drug Research Institute, Curtin University, Perth, Australia. 4. Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, Australia. 5. National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Abstract
INTRODUCTION AND AIMS: Concerns about crystal methamphetamine use and harm have increased in multiple countries. This paper describes how changes in the availability and use of crystal methamphetamine have impacted on methamphetamine-related harms in Australia. DESIGN AND METHODS: Data on methamphetamine use were obtained from population-level surveys, health service data and surveys of drug use among sentinel groups of ecstasy users and people who inject drugs. Data were obtained on seizures, arrests, clandestine laboratory detections, hospital separations, mental health unit admissions, drug telephone helpline calls and drug treatment episodes. Segmented linear regression models were fitted to identify changes in these series using log-transformed data where appropriate. RESULTS: The availability of crystal methamphetamine has increased as evidenced by increased laboratory detections, domestic seizures and purity of the seized drug. Population surveys do not report an increase in the number of people who used at least once in the past year. However, more users report using crystal methamphetamine rather than lower-purity powder methamphetamine and more regular use. Indicators of methamphetamine-related harms have increased in parallel with this change. Amphetamine-related helpline calls, drug treatment, arrests and hospital admissions for amphetamine disorders and psychosis all peaked in the mid-2000s, declined for several years and have increased steeply since 2010. DISCUSSION AND CONCLUSIONS: The increased availability and use of crystal methamphetamine have been associated with increased regular use and harms. Treatment is required for those experiencing problems and the capacity of health services to provide care needs to be enhanced.[Degenhardt L, Sara G, Connor JP, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2017;36:160-170].
INTRODUCTION AND AIMS: Concerns about crystal methamphetamine use and harm have increased in multiple countries. This paper describes how changes in the availability and use of crystal methamphetamine have impacted on methamphetamine-related harms in Australia. DESIGN AND METHODS: Data on methamphetamine use were obtained from population-level surveys, health service data and surveys of drug use among sentinel groups of ecstasy users and people who inject drugs. Data were obtained on seizures, arrests, clandestine laboratory detections, hospital separations, mental health unit admissions, drug telephone helpline calls and drug treatment episodes. Segmented linear regression models were fitted to identify changes in these series using log-transformed data where appropriate. RESULTS: The availability of crystal methamphetamine has increased as evidenced by increased laboratory detections, domestic seizures and purity of the seized drug. Population surveys do not report an increase in the number of people who used at least once in the past year. However, more users report using crystal methamphetamine rather than lower-purity powder methamphetamine and more regular use. Indicators of methamphetamine-related harms have increased in parallel with this change. Amphetamine-related helpline calls, drug treatment, arrests and hospital admissions for amphetamine disorders and psychosis all peaked in the mid-2000s, declined for several years and have increased steeply since 2010. DISCUSSION AND CONCLUSIONS: The increased availability and use of crystal methamphetamine have been associated with increased regular use and harms. Treatment is required for those experiencing problems and the capacity of health services to provide care needs to be enhanced.[Degenhardt L, Sara G, Connor JP, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2017;36:160-170].
Authors: Jonathan Brett; Claire E Wylie; Jacques Raubenheimer; Geoff K Isbister; Nick A Buckley Journal: Br J Clin Pharmacol Date: 2019-07-17 Impact factor: 4.335
Authors: Raminta Daniulaityte; Sydney M Silverstein; Timothy N Crawford; Silvia S Martins; William Zule; Angela J Zaragoza; Robert G Carlson Journal: Subst Use Misuse Date: 2020-05-22 Impact factor: 2.164
Authors: Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton Journal: Ann N Y Acad Sci Date: 2021-09-24 Impact factor: 6.499
Authors: Rachael M Lyons; Amy M Yule; Davida Schiff; Sarah M Bagley; Timothy E Wilens Journal: J Child Adolesc Psychopharmacol Date: 2019-06-27 Impact factor: 3.031
Authors: Lara N Coughlin; Lewei Allison Lin; Mary Jannausch; Mark A Ilgen; Erin E Bonar Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852
Authors: Reece Cossar; Mark Stoové; Stuart A Kinner; Paul Dietze; Campbell Aitken; Michael Curtis; Amy Kirwan; James R P Ogloff Journal: Health Justice Date: 2018-01-13
Authors: Alexandra Stuart; Amanda L Baker; Jenny Bowman; Kristen McCarter; Alexandra Mary Janice Denham; Nicole Lee; Kim Colyvas; Adrian Dunlop Journal: BMJ Open Date: 2017-09-07 Impact factor: 2.692